Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation

Chronic, inflammatory pain is an international health concern that severely diminishes individuals’ quality of life. Catalpol is an iridoid glycoside derived from the roots of Rehmannia glutinosa that possesses anti-inflammatory, antioxidant, and neuroprotective properties for the treating multiple...

Full description

Bibliographic Details
Main Authors: Baoxia Zhao, Jie Fu, Huadong Ni, Longsheng Xu, Chengfei Xu, Qiuli He, Chaobo Ni, Yahui Wang, Jiao Kuang, Mengjie Tang, Qiyang Shou, Ming Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.1010483/full
_version_ 1811235567362375680
author Baoxia Zhao
Baoxia Zhao
Jie Fu
Jie Fu
Huadong Ni
Longsheng Xu
Chengfei Xu
Qiuli He
Chaobo Ni
Yahui Wang
Jiao Kuang
Mengjie Tang
Qiyang Shou
Ming Yao
Ming Yao
author_facet Baoxia Zhao
Baoxia Zhao
Jie Fu
Jie Fu
Huadong Ni
Longsheng Xu
Chengfei Xu
Qiuli He
Chaobo Ni
Yahui Wang
Jiao Kuang
Mengjie Tang
Qiyang Shou
Ming Yao
Ming Yao
author_sort Baoxia Zhao
collection DOAJ
description Chronic, inflammatory pain is an international health concern that severely diminishes individuals’ quality of life. Catalpol is an iridoid glycoside derived from the roots of Rehmannia glutinosa that possesses anti-inflammatory, antioxidant, and neuroprotective properties for the treating multiple kinds of disorders. Nevertheless, catalpol’s impacts on inflammatory pain and its potential methods of action are still unclear. The purpose of this investigation is to determine the mechanism of catalpol to reduce the inflammatory pain behaviors in a rat model with complete Freund’s adjuvant (CFA). Catwalk, Von-Frey, and open field testing were performed for behavioral assessment. Western blot analysis and real-time quantitative PCR (RT-PCR) were employed to identify variations in molecular expression, while immunofluorescence was utilized to identify cellular localization. Catalpol effectively reduced CFA-induced mechanical allodynia and thermal hyperalgesia when injected intrathecally. Moreover, catalpol can regulate the HDAC4/PPAR-γ-signaling pathway in CFA rat spinal cord neurons. Meanwhile catalpol significantly decreased the expression of the NF-κB/NLRP3 inflammatory axis in the spinal cord of CFA rats. In addition, both in vivo and in vitro research revealed that catalpol treatment inhibited astrocyte activation and increase inflammatory factor expression. Interestingly, we also found that catalpol could alleviate peripheral pain by inhibiting tissue inflammation. Taken together, the findings declared that catalpol may inhibit inflammatory pain in CFA rats by targeting spinal cord and peripheral inflammation.
first_indexed 2024-04-12T11:53:11Z
format Article
id doaj.art-e4b6e5723d32464d909587af167e5395
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-12T11:53:11Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-e4b6e5723d32464d909587af167e53952022-12-22T03:34:06ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-10-011310.3389/fphar.2022.10104831010483Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammationBaoxia Zhao0Baoxia Zhao1Jie Fu2Jie Fu3Huadong Ni4Longsheng Xu5Chengfei Xu6Qiuli He7Chaobo Ni8Yahui Wang9Jiao Kuang10Mengjie Tang11Qiyang Shou12Ming Yao13Ming Yao14School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.Department of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.Department of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaDepartment of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaDepartment of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaDepartment of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaDepartment of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaDepartment of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaDepartment of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaDepartment of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaDepartment of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.Department of Anesthesiology and Pain Research Center, The First Hospital of Jiaxing Or The Affiliated Hospital of Jiaxing University, Jiaxing, ChinaChronic, inflammatory pain is an international health concern that severely diminishes individuals’ quality of life. Catalpol is an iridoid glycoside derived from the roots of Rehmannia glutinosa that possesses anti-inflammatory, antioxidant, and neuroprotective properties for the treating multiple kinds of disorders. Nevertheless, catalpol’s impacts on inflammatory pain and its potential methods of action are still unclear. The purpose of this investigation is to determine the mechanism of catalpol to reduce the inflammatory pain behaviors in a rat model with complete Freund’s adjuvant (CFA). Catwalk, Von-Frey, and open field testing were performed for behavioral assessment. Western blot analysis and real-time quantitative PCR (RT-PCR) were employed to identify variations in molecular expression, while immunofluorescence was utilized to identify cellular localization. Catalpol effectively reduced CFA-induced mechanical allodynia and thermal hyperalgesia when injected intrathecally. Moreover, catalpol can regulate the HDAC4/PPAR-γ-signaling pathway in CFA rat spinal cord neurons. Meanwhile catalpol significantly decreased the expression of the NF-κB/NLRP3 inflammatory axis in the spinal cord of CFA rats. In addition, both in vivo and in vitro research revealed that catalpol treatment inhibited astrocyte activation and increase inflammatory factor expression. Interestingly, we also found that catalpol could alleviate peripheral pain by inhibiting tissue inflammation. Taken together, the findings declared that catalpol may inhibit inflammatory pain in CFA rats by targeting spinal cord and peripheral inflammation.https://www.frontiersin.org/articles/10.3389/fphar.2022.1010483/fullcatalpolinflammatory painHDAC4/PPAR-γ -signaling pathwayNF-κB/NLRP3 inflammatory axisastrocyte activationperipheral pain
spellingShingle Baoxia Zhao
Baoxia Zhao
Jie Fu
Jie Fu
Huadong Ni
Longsheng Xu
Chengfei Xu
Qiuli He
Chaobo Ni
Yahui Wang
Jiao Kuang
Mengjie Tang
Qiyang Shou
Ming Yao
Ming Yao
Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation
Frontiers in Pharmacology
catalpol
inflammatory pain
HDAC4/PPAR-γ -signaling pathway
NF-κB/NLRP3 inflammatory axis
astrocyte activation
peripheral pain
title Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation
title_full Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation
title_fullStr Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation
title_full_unstemmed Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation
title_short Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation
title_sort catalpol ameliorates cfa induced inflammatory pain by targeting spinal cord and peripheral inflammation
topic catalpol
inflammatory pain
HDAC4/PPAR-γ -signaling pathway
NF-κB/NLRP3 inflammatory axis
astrocyte activation
peripheral pain
url https://www.frontiersin.org/articles/10.3389/fphar.2022.1010483/full
work_keys_str_mv AT baoxiazhao catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT baoxiazhao catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT jiefu catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT jiefu catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT huadongni catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT longshengxu catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT chengfeixu catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT qiulihe catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT chaoboni catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT yahuiwang catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT jiaokuang catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT mengjietang catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT qiyangshou catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT mingyao catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation
AT mingyao catalpolamelioratescfainducedinflammatorypainbytargetingspinalcordandperipheralinflammation